JUN 11, 2016 12:22 PM PDT

New Approach to Vaccines: Activate Only When Needed

WRITTEN BY: Carmen Leitch
A new vaccine has been developed that allows bacteria to grow inside the body, only actively fighting microbes that cause disease. This approach works in a completely nontraditional way; vaccines usually work to destroy bacteria before it has a chance to grow at all.
 Scanning electron micrograph of Streptococcus pneumoniae
Blaine Pfeifer, an Associate Professor of chemical and biological engineering at the University at Buffalo School of Engineering and Applied Sciences, and colleagues conducted the work, which was published in the Proceedings of the National Academy of Sciences and describes a vaccine responding to pneumococcus. 

"With conventional vaccines, the approach has been: 'What bacteria do we want to target and how,'" says Charles Jones, a study author who founded Abcombi Biosciences, a company spearheading the effort to bring this vaccine to market. "Our strategy is to shift the paradigm to which diseases do we want to prevent."

Pneumococcus is the common name for Streptococcus pneumoniae, and pneumococcal infections can result in many types of illnesses such as ear infections, pneumonia and meningitis. "These are very serious illnesses that we haven't been able to completely suppress. The vaccine we're developing could finally get that job done," says Pfeifer.

 According to the CDC, roughly 900,000 Americans contract pneumococcal pneumonia each year, causing an estimated 400,000 hospitalizations. It is fatal for 5-7 percent - about 3,700 patients. Outside the United States, especially in underdeveloped nations, the number of deaths is much higher.

Doctors have long relied on medications like penicillin to treat sickness caused by pneumococcus, and their effectiveness has been in decline for a long time. That problem led to the creation of vaccines, which have helped to reduce illness and death. But, vaccines that are commonly used only target a small number of strains of the virulent bacteria - the ones that cause the most serious illnesses. They find the bacteria by identifying a sugar coating that surrounds it.

This new vaccine instead uses proteins on the surface of the bacteria as the identifying feature. Tests that evaluated the new vaccine showed that it defended against 12 strains of the bacteria with 100 percent effectiveness. Computer models suggest it could be used against many more strains but further testing is needed to confirm.

With multiple diseases caused by a variety of strains, this approach could be a great way to respond to myriad illnesses. 
 (A) S. pneumoniae grows in the nasal passages, producing a bacterial biofilm that provides protection. External triggers like viral infection prompt the active release of virulent pneumococci that disseminate and cause disease. (B) Leading vaccination strategies [polysaccharide conjugate vaccines] mediate protection against some bacterial serotypes by clearing pneumococci before biofilm establishment. But clearing all bacteria opens vulnerabilities to colonization by nonvaccine serotypes or other bacterial species. (C) The strategy featured in this work mediates clearance of only virulent biofilm-released bacteria while keeping the presence of the preexisting biofilm. Source: PNAS
The novel strategy of this vaccine is to let bacteria live, so long as it does not cause any harm to the body. It teaches the immune system to only attack when the proteins on the surface of the bacterial coating break free. “That’s the signal that this bacteria is becoming a troublemaker, that’s its threatening the body and that it’s necessary to fight back,” Pfeifer says.

The vaccine has so far been tested and found to be effective in animals; Abcombi currently leads efforts to conduct trials in humans.

Sources: CDC, University at Buffalo News Center via AAAS, PNAS
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
FEB 02, 2020
Microbiology
FEB 02, 2020
A Potential Treatment for MERS is Found
A coronavirus causes MERS, which currently has no treatment. This work may help change that....
MAR 05, 2020
Microbiology
MAR 05, 2020
Researchers Learn How Gut Microbes Can Promote Heart Disease
The microbes in our gastrointestinal tract, collectively known as the gut microbiome, have a powerful impact on our health and well-being....
MAR 09, 2020
Genetics & Genomics
MAR 09, 2020
Researchers Alter How Bacteria Communicate
The bacterium Escherichia coli comes in many forms, and researchers have used a harmless strain of it to redesign how the microbes communicate....
MAR 30, 2020
Genetics & Genomics
MAR 30, 2020
Scientists Discover an Antibiotic Resistance Gene
The gene enables bacteria to resist the effects of an aminoglycoside antibiotic called plazomycin....
APR 01, 2020
Clinical & Molecular DX
APR 01, 2020
One dollar kit diagnoses COVID-19 in 10 minutes
Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 infection in just 10 minutes. In th...
MAR 31, 2020
Space & Astronomy
MAR 31, 2020
Can Viruses Survive in Outer Space?
Outer space is often depicted as a harsh environment. It’s effectively an airless vacuum, and anything residing there would be subjected to high amou...
Loading Comments...